Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlas Antibodies
Stockholm, Swedenatlasantibodies.com ↗
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
Atlas Antibodies offers over 21,000 rigorously validated antibodies, antigens, and protein mass spectrometry standards with global distribution, mainly targeting the entire human proteome for use in research, diagnostics, and clinical proteomics[4][6][7].
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- AntibodyPolyclonal antibodyMonoclonal antibodyRecombinant protein
- Industry
- Non-Drug Biotech
02
Partnerships
Sigma-Aldrich (distribution, branded as 'Prestige Antibodies')
Beyond the preview
Go deeper on Atlas Antibodies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atlas Antibodies.